A Response to ‘Another Legislative Attempt to Revive Gene Patenting’
Including purified and isolated materials as eligible subject matter under 35 U.S.C. ยงย 101 can benefit patients, researchers, and innovation.
Patent Eligibility Restoration Act of 2022
-
Read more: A Response to ‘Another Legislative Attempt to Revive Gene Patenting’